Evaluation of Intraocular Pressure and Mean Ocular Perfusion Pressure Before and After Intravitreal Injection of Bevacizumab

Aim: To investigate the effect of intravitreal bevacizumab injection on intra ocular pressure and mean ocular perfusion pressure (MOPP). Methods: This prospective observational study was conducted in the Department of Ophthalmology, BMU, Dhaka from March 2018 to August 2020. Within the period, total 85 cases of different vitreoretinal diseases those meet the inclusion criteria were included in study after receiving informed consent from the patient. Bevacizumab was injected intravitreally with aseptic precaution in ophthalmology operation room. IOP and MOPP were measured just before injection, within 30 minutes after injection,1 day and 1 week after injection of bevacizumab. Data were collected by data collection sheet and all the data were analyzed statistically by using statistical package for social science (SPSS-26). The results were expressed as frequency, percentage and mean ± SD. Result: In this study, mean IOP is 13.39±3.92 mmHg before injection, 16.65±4.48 mmHg within 30 min after injection, 13.40±3.50 mmHg at 1 day after injection and 13.12±3.27 mmHg at 7 days after injection. Mean MOPP is 50.94±6.87mmHg before injection, 48.12±7.15mmHg within 30 min after injection, 50.47±6.64 mmHg 1 day after injection and 50.66±4.98mmHg 7 days after injection. One way ANOVA was performed to compare IOP and MOPP among time points (pre and post at 30 minutes, day 1 and day 7). For multiple test (comparison among groups) Bonferroni adjustment was applied. The change of IOP and MOPP is significantly different between before and within 30 minutes after injection (p< 0.05) but between before and 1 day &7 days after injection it is not significant different (p > 0.05) Conclusion: After analyzing the results of present study it can be concluded that IOP is significantly increased within 30 minutes after injection and recover to their pre-injection value within 1 day after injection, this observation continued on 7th day follow up also. And MOPP is significantly decreased within 30 minutes after injection and recover to their pre-injection value within 1 days after injection and this observation continued on 7th day follow up also. J.Natl.Inst.Ophthalmol.2025;8(2): 15-19

Authors

Institutions

Publication Details

Journal
Journal of National Institute of Ophthalmology
Published
2026-11-19
DOI
https://doi.org/10.3329/jnio.v8i2.95125
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of Intraocular Pressure and Mean Ocular Perfusion Pressure Before and After Intravitreal Injection of Bevacizumab

Naoroze Ferdous Romance, Fatema Ferdous Ara, Dr. Md. Saiful Arefin, Fatema Tuj Zohra et al.
Journal of National Institute of Ophthalmology
Retinal Diseases and Treatments
article

Evaluation of Intraocular Pressure and Mean Ocular Perfusion Pressure Before and After Intravitreal Injection of Bevacizumab

Naoroze Ferdous Romance, Fatema Ferdous Ara, Dr. Md. Saiful Arefin, Fatema Tuj Zohra, Nasrin Afrose
article en

Abstract

Aim: To investigate the effect of intravitreal bevacizumab injection on intra ocular pressure and mean ocular perfusion pressure (MOPP). Methods: This prospective observational study was conducted in the Department of Ophthalmology, BMU, Dhaka from March 2018 to August 2020. Within the period, total 85 cases of different vitreoretinal diseases those meet the inclusion criteria were included in study after receiving informed consent from the patient. Bevacizumab was injected intravitreally with aseptic precaution in ophthalmology operation room. IOP and MOPP were measured just before injection, within 30 minutes after injection,1 day and 1 week after injection of bevacizumab. Data were collected by data collection sheet and all the data were analyzed statistically by using statistical package for social science (SPSS-26). The results were expressed as frequency, percentage and mean ± SD. Result: In this study, mean IOP is 13.39±3.92 mmHg before injection, 16.65±4.48 mmHg within 30 min after injection, 13.40±3.50 mmHg at 1 day after injection and 13.12±3.27 mmHg at 7 days after injection. Mean MOPP is 50.94±6.87mmHg before injection, 48.12±7.15mmHg within 30 min after injection, 50.47±6.64 mmHg 1 day after injection and 50.66±4.98mmHg 7 days after injection. One way ANOVA was performed to compare IOP and MOPP among time points (pre and post at 30 minutes, day 1 and day 7). For multiple test (comparison among groups) Bonferroni adjustment was applied. The change of IOP and MOPP is significantly different between before and within 30 minutes after injection (p< 0.05) but between before and 1 day &7 days after injection it is not significant different (p > 0.05) Conclusion: After analyzing the results of present study it can be concluded that IOP is significantly increased within 30 minutes after injection and recover to their pre-injection value within 1 day after injection, this observation continued on 7th day follow up also. And MOPP is significantly decreased within 30 minutes after injection and recover to their pre-injection value within 1 days after injection and this observation continued on 7th day follow up also. J.Natl.Inst.Ophthalmol.2025;8(2): 15-19

Journal of National Institute of OphthalmologyVol. 8(2)
National Institute of Neurosciences & Hospital (BD), National Institute of Cardiovascular Diseases (BD)
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon